RASHMI KRISHNA MURTHY to Cohort Studies
This is a "connection" page, showing publications RASHMI KRISHNA MURTHY has written about Cohort Studies.
Connection Strength
0.041
-
Preclinical and Clinical Efficacy of Trastuzumab Deruxtecan in Breast Cancer Brain Metastases. Clin Cancer Res. 2023 01 04; 29(1):174-182.
Score: 0.022
-
Subgroup analysis of nelipepimut-S plus GM-CSF combined with trastuzumab versus trastuzumab alone to prevent recurrences in patients with high-risk, HER2 low-expressing breast cancer. Clin Immunol. 2021 04; 225:108679.
Score: 0.019